These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38899488)

  • 41. Melanoma-inhibiting activity assay predicts survival in patients receiving a therapeutic cancer vaccine after complete resection of American Joint Committee on Cancer Stage III Melanoma.
    Faries MB; Gupta RK; Ye X; Hsueh EC; Morton DL
    Ann Surg Oncol; 2004 Jan; 11(1):85-93. PubMed ID: 14699039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients.
    Sanmamed MF; Fernández-Landázuri S; Rodríguez C; Lozano MD; Echeveste JI; Pérez Gracia JL; Alegre E; Carranza O; Zubiri L; Martín-Algarra S; González A
    Clin Chim Acta; 2014 Feb; 429():168-74. PubMed ID: 24333389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro.
    Callejo SA; Marshall JC; Cools-Lartigue J; Saraiva VS; Burnier MN
    Melanoma Res; 2004 Apr; 14(2):91-5. PubMed ID: 15057037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aptamer-Based ELISA Assay for Highly Specific and Sensitive Detection of Zika NS1 Protein.
    Lee KH; Zeng H
    Anal Chem; 2017 Dec; 89(23):12743-12748. PubMed ID: 29120623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
    Bosserhoff AK; Buettner R
    Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitive Detection of Tumor Cells Using Protein Nanoparticles with Multiple Displays of DNA Aptamers and Bioluminescent Reporters.
    Nishida K; Wang G; Kobatake E; Mie M
    ACS Biomater Sci Eng; 2023 Sep; 9(9):5260-5269. PubMed ID: 37642536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center Analysis.
    Glaser N; Petzold A; Wessely A; Kaufmann MD; Koch EAT; Knorr H; Voskens C; Heppt MV; Berking C; Erdmann M
    Anticancer Res; 2023 Oct; 43(10):4525-4532. PubMed ID: 37772590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a biosensor for electrochemical detection of tumor-associated proteins in blood plasma of cancer patients by aptamers.
    Zamay GS; Zamay TN; Kolovskaya OS; Krat AV; Glazyrin YE; Dubinina AV; Zamay AS
    Dokl Biochem Biophys; 2016; 466():70-3. PubMed ID: 27025492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An aptamer-binding DNA walking machine for sensitive electrochemiluminescence detection of tumor exosomes.
    Feng QM; Ma P; Cao QH; Guo YH; Xu JJ
    Chem Commun (Camb); 2019 Dec; 56(2):269-272. PubMed ID: 31807735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum markers in skin melanoma--preliminary study.
    Dumitraşcu G; Constantin C; Manda G; Hristescu S; Mărgaritescu I; Chiriţă D; Neagu M
    Roum Arch Microbiol Immunol; 2009; 68(3):125-35. PubMed ID: 20361532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and characterization of novel 2'-F-RNA aptamers specific to human total and glycated hemoglobins.
    Davydova A; Vorobyeva M; Bashmakova E; Vorobjev P; Krasheninina O; Tupikin A; Kabilov M; Krasitskaya V; Frank L; Venyaminova A
    Anal Biochem; 2019 Apr; 570():43-50. PubMed ID: 30742800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aptamer-based protein detection using a bioluminescent fusion protein.
    Akter F; Mie M; Kobatake E
    Analyst; 2012 Nov; 137(22):5297-301. PubMed ID: 23013644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aptamer-based detection and quantitative analysis of human immunoglobulin E in capillary electrophoresis with chemiluminescence detection.
    Liu YM; Cao JT; Liu YY; Zhang JJ; Zhou M; Huang KJ; Chen YH; Ren SW
    Electrophoresis; 2015 Oct; 36(19):2413-8. PubMed ID: 26095306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma markers for identifying patients with metastatic melanoma.
    Kluger HM; Hoyt K; Bacchiocchi A; Mayer T; Kirsch J; Kluger Y; Sznol M; Ariyan S; Molinaro A; Halaban R
    Clin Cancer Res; 2011 Apr; 17(8):2417-25. PubMed ID: 21487066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.
    Bosserhoff AK; Stoll R; Sleeman JP; Bataille F; Buettner R; Holak TA
    Lab Invest; 2003 Nov; 83(11):1583-94. PubMed ID: 14615412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A time-resolved luminescent competitive assay to detect L-selectin using aptamers as recognition elements.
    Cywiński PJ; Olejko L; Löhmannsröben HG
    Anal Chim Acta; 2015 Aug; 887():209-215. PubMed ID: 26320804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.